Major U.S. health insurers have agreed to cover the Wegovy weight-loss drug for certain people on Medicare with heart conditions. CVS Health, Elevance Health, and Kaiser Permanente will now reimburse the drug for those who meet specific criteria. However, Eli Lilly has disclosed potential shortages of their Zepbound weight loss drug due to high demand. In other news, despite concerns about influencing medical practice, financial ties between drug and device makers and physicians remain prevalent. A recent analysis found that over a 10-year span, billions of dollars in payments were made to hundreds of thousands of physicians, mostly related to marketed medical products like blood thinners and a robotic surgical system.
Source link
We’re reading about Wegovy insurance coverage and Zepbound
